A comprehensive view of J.P. Morgan Healthcare Conference. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Moderna reports preliminary product sales of US$6.7B for 2023 at J.P. Morgan Healthcare Conference; Moderna expects to generate US$4.0B in revenues in 2024 from its COVID-19 and RSV vaccines
Published:
January 09, 2024
by Zack's Commentary
|
BioNTech announces 2024 strategic priorities, including having 10 or more potential registrational trials by end-2024 to be commercially ready by the end of 2025; the company forecasts revenues of about €3.0B in 2024
Published:
January 09, 2024
by BioNTech SE
|
Sage Therapeutics to Provide Business Updates at 42nd Annual J.P. Morgan Healthcare Conference
Published:
January 08, 2024
by Sage Therapeutics
|
Labcorp executive management team to participate in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 9 at 4:30 p.m.
Published:
January 04, 2024
by ENP Newswire
|
Pfizer invites investors and public to webcast discussion with CEO at the J.P. Morgan Healthcare Conference; registration, transcript and replay available through their official website
Published:
January 04, 2024
by ENP Newswire
|
Ask us about our Health Care Sector market view